Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-08-05 16:33:08 ET · period of report 2026-08-03 · accession 0001193210-26-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-05 16:33 | 2026-08-03 | JAZZ | COZADD BRUCE C | Dir | S - Sale | $252.98 | -6,000 | 360.7K | -2% | -$1.52M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-08-03 | S | D | 6,000 | $252.98 | 360,682 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |